A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease
Public ClinicalTrials.gov record NCT00912288. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled 26-Week Trial To Evaluate The Efficacy And Safety Of Dimebon In Patients With Moderate-To-Severe Alzheimer's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
No Dimebon clinical data exist yet in patients with disease that has advanced to the moderate-to-severe stage. Therefore, this study evaluates the safety and efficacy of Dimebon in patients with moderate-to-severe AD who are receiving existing background therapy with memantine.
Study identification
- NCT ID
- NCT00912288
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 86 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2009 (Type not available)
- Primary completion
- Aug 2010 (Actual)
- Completion
- Aug 2010 (Actual)
- Last update posted
- Oct 2, 2012
2009 – 2010
United States locations
- U.S. sites
- 21
- U.S. states
- 14
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Phoenix | Arizona | 85006 | — |
| Pfizer Investigational Site | Costa Mesa | California | 92626 | — |
| Pfizer Investigational Site | Encino | California | 91316 | — |
| Pfizer Investigational Site | Los Alamitos | California | 90720 | — |
| Pfizer Investigational Site | Newport Beach | California | 92660-2452 | — |
| Pfizer Investigational Site | Newport Beach | California | 92663 | — |
| Pfizer Investigational Site | Denver | Colorado | 80218 | — |
| Pfizer Investigational Site | New Haven | Connecticut | 06510 | — |
| Pfizer Investigational Site | Brooksville | Florida | 34601 | — |
| Pfizer Investigational Site | Delray Beach | Florida | 33445 | — |
| Pfizer Investigational Site | West Palm Beach | Florida | 33407 | — |
| Pfizer Investigational Site | Indianapolis | Indiana | 46260 | — |
| Pfizer Investigational Site | Lexington | Kentucky | 40503 | — |
| Pfizer Investigational Site | Pittsfield | Massachusetts | 01201 | — |
| Pfizer Investigational Site | Princeton | New Jersey | 08540 | — |
| Pfizer Investigational Site | Rochester | New York | 14620 | — |
| Pfizer Investigational Site | Syracuse | New York | 13210 | — |
| Pfizer Investigational Site | Norristown | Pennsylvania | 19401 | — |
| Pfizer Investigational Site | East Providence | Rhode Island | 02914 | — |
| Pfizer Investigational Site | Cordova | Tennessee | 38018 | — |
| Pfizer Investigational Site | Middleton | Wisconsin | 53562 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 26 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00912288, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 2, 2012 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00912288 live on ClinicalTrials.gov.